Cargando…
Cost-effectiveness of Paxlovid in reducing severe COVID-19 and mortality in China
OBJECTIVES: To assess the cost-effectiveness of Paxlovid in reducing severe COVID-19 and its associated morality, and to investigate the affordable price of Paxlovid in China. MATERIALS AND METHODS: Using a Markov model, two interventions by Paxlovid prescription (with and without prescription) were...
Autores principales: | Zhang, Weina, Li, Lanfang, Zhou, Zhen, Liu, Qiao, Wang, Guan, Liu, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315619/ https://www.ncbi.nlm.nih.gov/pubmed/37404282 http://dx.doi.org/10.3389/fpubh.2023.1174879 |
Ejemplares similares
-
Cost-effectiveness analysis of vaccination against COVID-19 in China
por: Zhou, Huixuan, et al.
Publicado: (2023) -
Cost-effectiveness of ensartinib, crizotinib, ceritinib, alectinib, brigatinib and lorlatinib in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer in China
por: Luo, Xia, et al.
Publicado: (2022) -
Cost-Effectiveness Analysis of Vedolizumab Compared With Infliximab in Anti-TNF-α-Naïve Patients With Moderate-to-Severe Ulcerative Colitis in China
por: Zhou, Ting, et al.
Publicado: (2021) -
Gender Differences in Patients With COVID-19: Focus on Severity and Mortality
por: Jin, Jian-Min, et al.
Publicado: (2020) -
Projected COVID-19 Mortality Reduction From Paxlovid Rollout
por: Khunte, Mihir, et al.
Publicado: (2023)